Afutuzumab ELISA Kit,Abbexa,abx395063
Afutuzumab ELISA Kit is a quantitative ELISA kit for detection of Afutuzumab.Afutuzumab is a monoclonal antibody that targets the CD20 antigen expressed on the surface of pre-B and mature B lymphocytes. Upon binding to CD20, obinutuzumab mediates B-cell lysisthrough (1) engagement of immune effector cells (2) by directly activating intracellular death signaling pathways (direct cell death), and/or (3) activation of the complement cascade. The immune effector cell mechanisms include antibody-dependent cellular cytotoxicity (ADCC) and antibodydependent cellular phagocytosis.As an antibody with reduced fucose content, obinutuzumab induces greater ADCC activity than rituximab in vitro using human cancer cell lines. Afutuzumab also demonstrated an increased ability to induce direct cell death when compared to rituximab. Afutuzumab binds to FcγRIII using purified proteins with a higher affinity than rituximab. Afutuzumab and rituximab bind with similar affinity to overlapping epitopes on CD20.
Reactivity
Human
Application
ELISA
Platform ID
BAB552695713

Abbexa
Contact
Tel: +44 (0) 1223 755950
Fax: +44 (0) 1223 755951
Email:
Product Specifications
Specifications
NameAfutuzumab ELISA Kit
Cat. No.abx395063
ReactivityHuman
ApplicationELISA
Working DilutionsOptimal dilutions/concentrations should be determined by the end user.
StorageShipped at 4 °C. Upon receipt, store the kit according to the storage instruction in the kit's manual.
Regulatory StatusResearch Use Only
Category Paths
- Products>ELISA & Assay Kits>ELISA Kits
Request a product
Please provide the required information below so that we can quickly source your products.
